234 related articles for article (PubMed ID: 28603028)
1. Targeting of p32 in peritoneal carcinomatosis with intraperitoneal linTT1 peptide-guided pro-apoptotic nanoparticles.
Hunt H; Simón-Gracia L; Tobi A; Kotamraju VR; Sharma S; Nigul M; Sugahara KN; Ruoslahti E; Teesalu T
J Control Release; 2017 Aug; 260():142-153. PubMed ID: 28603028
[TBL] [Abstract][Full Text] [Related]
2. Peptide-guided nanoparticles for glioblastoma targeting.
Säälik P; Lingasamy P; Toome K; Mastandrea I; Rousso-Noori L; Tobi A; Simón-Gracia L; Hunt H; Paiste P; Kotamraju VR; Bergers G; Asser T; Rätsep T; Ruoslahti E; Bjerkvig R; Friedmann-Morvinski D; Teesalu T
J Control Release; 2019 Aug; 308():109-118. PubMed ID: 31255690
[TBL] [Abstract][Full Text] [Related]
3. Peritoneal Carcinomatosis Targeting with Tumor Homing Peptides.
Simón-Gracia L; Hunt H; Teesalu T
Molecules; 2018 May; 23(5):. PubMed ID: 29772690
[TBL] [Abstract][Full Text] [Related]
4. Hyaluronan-binding peptide for targeting peritoneal carcinomatosis.
Ikemoto H; Lingasamy P; Anton Willmore AM; Hunt H; Kurm K; Tammik O; Scodeller P; Simón-Gracia L; Kotamraju VR; Lowy AM; Sugahara KN; Teesalu T
Tumour Biol; 2017 May; 39(5):1010428317701628. PubMed ID: 28468593
[TBL] [Abstract][Full Text] [Related]
5. Tumor-Penetrating Nanosystem Strongly Suppresses Breast Tumor Growth.
Sharma S; Kotamraju VR; Mölder T; Tobi A; Teesalu T; Ruoslahti E
Nano Lett; 2017 Mar; 17(3):1356-1364. PubMed ID: 28178415
[TBL] [Abstract][Full Text] [Related]
6. iRGD peptide conjugation potentiates intraperitoneal tumor delivery of paclitaxel with polymersomes.
Simón-Gracia L; Hunt H; Scodeller P; Gaitzsch J; Kotamraju VR; Sugahara KN; Tammik O; Ruoslahti E; Battaglia G; Teesalu T
Biomaterials; 2016 Oct; 104():247-57. PubMed ID: 27472162
[TBL] [Abstract][Full Text] [Related]
7. Paclitaxel-Loaded Polymersomes for Enhanced Intraperitoneal Chemotherapy.
Simón-Gracia L; Hunt H; Scodeller PD; Gaitzsch J; Braun GB; Willmore AM; Ruoslahti E; Battaglia G; Teesalu T
Mol Cancer Ther; 2016 Apr; 15(4):670-9. PubMed ID: 26880267
[TBL] [Abstract][Full Text] [Related]
8. A tumor-penetrating peptide enhances circulation-independent targeting of peritoneal carcinomatosis.
Sugahara KN; Scodeller P; Braun GB; de Mendoza TH; Yamazaki CM; Kluger MD; Kitayama J; Alvarez E; Howell SB; Teesalu T; Ruoslahti E; Lowy AM
J Control Release; 2015 Aug; 212():59-69. PubMed ID: 26071630
[TBL] [Abstract][Full Text] [Related]
9. Application of polymersomes engineered to target p32 protein for detection of small breast tumors in mice.
Simón-Gracia L; Scodeller P; Fuentes SS; Vallejo VG; Ríos X; San Sebastián E; Sidorenko V; Di Silvio D; Suck M; De Lorenzi F; Rizzo LY; von Stillfried S; Kilk K; Lammers T; Moya SE; Teesalu T
Oncotarget; 2018 Apr; 9(27):18682-18697. PubMed ID: 29721153
[TBL] [Abstract][Full Text] [Related]
10. The safe and effective intraperitoneal chemotherapy with cathepsin B-specific doxorubicin prodrug nanoparticles in ovarian cancer with peritoneal carcinomatosis.
Kim J; Shim MK; Cho YJ; Jeon S; Moon Y; Choi J; Kim J; Lee J; Lee JW; Kim K
Biomaterials; 2021 Dec; 279():121189. PubMed ID: 34695659
[TBL] [Abstract][Full Text] [Related]
11. [Antitumor and antimetastatic effect of antimicrobial peptide conjugated with tumor homing peptide TMTP1 on the transplanted prostate cancer and gastric cancer in nude mice].
Ma XY; Li S; Luo DF; Liu RH; Lu YP; Wang SX; Ma D; Xi L
Zhonghua Zhong Liu Za Zhi; 2013 Oct; 35(10):737-41. PubMed ID: 24378093
[TBL] [Abstract][Full Text] [Related]
12. Effect of bevacizumab, a humanized monoclonal antibody to vascular endothelial growth factor, on peritoneal metastasis of MNK-45P human gastric cancer in mice.
Ninomiya S; Inomata M; Tajima M; Ali AT; Ueda Y; Shiraishi N; Kitano S
J Surg Res; 2009 Jun; 154(2):196-202. PubMed ID: 19329124
[TBL] [Abstract][Full Text] [Related]
13. New p32/gC1qR Ligands for Targeted Tumor Drug Delivery.
Paasonen L; Sharma S; Braun GB; Kotamraju VR; Chung TD; She ZG; Sugahara KN; Yliperttula M; Wu B; Pellecchia M; Ruoslahti E; Teesalu T
Chembiochem; 2016 Apr; 17(7):570-5. PubMed ID: 26895508
[TBL] [Abstract][Full Text] [Related]
14. Bi-specific tenascin-C and fibronectin targeted peptide for solid tumor delivery.
Lingasamy P; Tobi A; Haugas M; Hunt H; Paiste P; Asser T; Rätsep T; Kotamraju VR; Bjerkvig R; Teesalu T
Biomaterials; 2019 Oct; 219():119373. PubMed ID: 31374479
[TBL] [Abstract][Full Text] [Related]
15. [Intraoperative and postoperative intra-peritoneal administration of peptide PIII inhibits peritoneal metastasis of gastric cancer].
Bai FH; Yang L; Ji Q; Zhang YQ; Liu ZX; Wang ZZ; Yan L; Wang JB; Jin HF; Li TT
Zhonghua Yi Xue Za Zhi; 2006 Dec; 86(46):3260-3. PubMed ID: 17313805
[TBL] [Abstract][Full Text] [Related]
16. Tumor-penetrating peptide for systemic targeting of Tenascin-C.
Lingasamy P; Tobi A; Kurm K; Kopanchuk S; Sudakov A; Salumäe M; Rätsep T; Asser T; Bjerkvig R; Teesalu T
Sci Rep; 2020 Apr; 10(1):5809. PubMed ID: 32242067
[TBL] [Abstract][Full Text] [Related]
17. Proapoptotic peptide-mediated cancer therapy targeted to cell surface p32.
Agemy L; Kotamraju VR; Friedmann-Morvinski D; Sharma S; Sugahara KN; Ruoslahti E
Mol Ther; 2013 Dec; 21(12):2195-204. PubMed ID: 23959073
[TBL] [Abstract][Full Text] [Related]
18. CD44-targeting for antitumor drug delivery: a new SN-38-hyaluronan bioconjugate for locoregional treatment of peritoneal carcinomatosis.
Serafino A; Zonfrillo M; Andreola F; Psaila R; Mercuri L; Moroni N; Renier D; Campisi M; Secchieri C; Pierimarchi P
Curr Cancer Drug Targets; 2011 Jun; 11(5):572-85. PubMed ID: 21486216
[TBL] [Abstract][Full Text] [Related]
19. Treatment of peritoneal carcinomatosis by targeted delivery of the radio-labeled tumor homing peptide bi-DTPA-[F3]2 into the nucleus of tumor cells.
Drecoll E; Gaertner FC; Miederer M; Blechert B; Vallon M; Müller JM; Alke A; Seidl C; Bruchertseifer F; Morgenstern A; Senekowitsch-Schmidtke R; Essler M
PLoS One; 2009 May; 4(5):e5715. PubMed ID: 19479088
[TBL] [Abstract][Full Text] [Related]
20. Homing Peptides for Cancer Therapy.
Lingasamy P; Teesalu T
Adv Exp Med Biol; 2021; 1295():29-48. PubMed ID: 33543454
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
